Intranasal H1/H3 dual antagonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intranasal H1/H3 dual antagonist, covering 2017-08-10 to 2017-08-10. Get the full timeline:
Most recent: Clinical Trial Update: Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects [Phase 1]